Prenetics Global Ltd (PRE) bonds

PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 10/30

$16.51−0.21 (-1.26%)

Close on Nov 13, 2026Market cap $278.59MP/E –Yield –

Debt

Borrowings on the balance sheet, Dec 31, 2025

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Individual notes, bonds and loans

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Parsed from the XBRL in Prenetics Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on May 1, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRE.

Revenue growth479.8% · median -5.7%

Gross margin52.8% · median 63.1%

Operating margin-48.1% · median -22.2%

Net margin-40.8% · median 0.6%

Advertisement
300 × 250

See a number that looks wrong?